CSIMarket Company Name, Ticker, Competitors, else..


Tango Therapeutics Inc   (NASDAQ: TNGX)
Other Ticker:  
 

Tango Therapeutics Inc

TNGX's Fundamental analysis



Tango Therapeutics Inc 's sales fell by -16.67 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1577

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.44 %

Tango Therapeutics Inc net loss increased from $-38 millions, to $-40 millions in first quarter of 2025,

• More on TNGX's Growth


Tango Therapeutics Inc
realized a net loss in trailing twelve months.

Tango Therapeutics Inc realized cash reduction of $ -0.02 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.


• More on TNGX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 525,513
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.51

Tango Therapeutics Inc
realized net loss in trailing twelve months.

Tango Therapeutics Inc realized cash outflow of $ -0.02per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.

Tango Therapeutics Inc Price to Book Ratio is at 4.56 lower than Industry Avg. of 34.87. and higher than S&P 500 Avg. of 0.01

• More on TNGX's Valuation

•  Market Capitalization (Millions $) 760
•  Shares Outstanding (Millions) 110
•  Employees 78
•  Revenues (TTM) (Millions $) 41
•  Net Income (TTM) (Millions $) -132
•  Cash Flow (TTM) (Millions $) -3
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 525,513
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 1.51

•  Market Capitalization (Millions $) 760
•  Shares Outstanding (Millions) 110
•  Employees 78
•  Revenues (TTM) (Millions $) 41
•  Net Income (TTM) (Millions $) -132
•  Cash Flow (TTM) (Millions $) -3
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 6.26
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.64
•  Asset Turnover Ratio (TTM) 0.14
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com